Nuo Therapeutics, Inc. (AURX)

Nuo Therapeutics Revenue

Nuo Therapeutics had revenue of $1.30M in the quarter ending March 31, 2026, with 168.82% growth. This brings the company's revenue in the last twelve months to $4.13M, up 155.81% year-over-year. In the year 2025, Nuo Therapeutics had annual revenue of $3.31M with 142.72% growth.

• Revenue (ttm): 4.13M
• Revenue Growth: +155.81%
• P/S Ratio: 11.60
• Revenue / Employee: 413.12K
• Employees: 10
• Market Cap: 47.92M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.31M	1.95M	142.72%
Dec 31, 2024	1.37M	756.65K	124.34%
Dec 31, 2023	608.53K	496.28K	442.12%
Dec 31, 2022	112.25K	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 23, 2026

Data Sources Report a data error